These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 16753758

  • 1. Favourable outcome of pulmonary zygomycosis in haematological malignancy.
    Opeskin K, Sheorey H, Wright G, Nandurkar H.
    Pathology; 2006 Jun; 38(3):271-3. PubMed ID: 16753758
    [No Abstract] [Full Text] [Related]

  • 2. Challenges in the management of invasive pulmonary zygomycosis: the Alfred experience.
    Saxena P, Shen SH, Morrissey O, Gooi JH.
    ANZ J Surg; 2015 Oct; 85(10):700-1. PubMed ID: 26429509
    [No Abstract] [Full Text] [Related]

  • 3. Lipid-based amphotericin in pulmonary zygomycosis: safety and efficacy of high exposure in a renal allograft recipient.
    Crompton JA, Alexander D, Somerville T, Shihab FS.
    Transpl Infect Dis; 2004 Dec; 6(4):183-7. PubMed ID: 15762937
    [Abstract] [Full Text] [Related]

  • 4. Successful treatment of pulmonary zygomycosis in two transplant recipients with liposomal amphotericin B and partial surgical resection followed by posaconazole.
    Cooke DT, Pagani FD, Kaul DR, Cooke KR, Lau CL, Riddell J.
    Mycoses; 2010 Mar 01; 53(2):163-7. PubMed ID: 19207843
    [No Abstract] [Full Text] [Related]

  • 5. Surgical resection and liposomal amphotericin B to treat cavitary pulmonary zygomycosis in a patient with diabetes.
    Hua-Ping Z, Jian L, Jing-Bin H, Jie G, Guo-Xin M, Yan-Hong J, Li-Xin X.
    Respir Care; 2011 Nov 01; 56(11):1837-9. PubMed ID: 21605482
    [Abstract] [Full Text] [Related]

  • 6. An immunocompromised patient with necrotic chin lesions.
    Khan FA, Vinjamuri M, Sarwari A.
    Clin Infect Dis; 2006 Jan 15; 42(2):242-3, 296-7. PubMed ID: 16363069
    [No Abstract] [Full Text] [Related]

  • 7. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.
    Chamilos G, Lewis RE, Kontoyiannis DP.
    Clin Infect Dis; 2008 Aug 15; 47(4):503-9. PubMed ID: 18611163
    [Abstract] [Full Text] [Related]

  • 8. A 19-year-old man with progressive lung infiltrates.
    Tonelli AR, Olson EL.
    Cleve Clin J Med; 2009 Nov 15; 76(11):635-8. PubMed ID: 19884291
    [No Abstract] [Full Text] [Related]

  • 9. [Zygomycosis following liver transplantation in adults: report of three cases].
    Brandão A, Marroni CA, Cerski CT, Gleisner AL, Zanotelli ML, Cantisani G.
    Rev Soc Bras Med Trop; 2003 Nov 15; 36(6):729-33. PubMed ID: 15049114
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Diagnosis and treatment of cutaneous zygomycosis.
    Visser DH, van den Berg YL, van Furth AM, Oomen MW, Schouten-van Meeteren AY, Pajkrt D, van den Bos C, van Well GT.
    Pediatr Infect Dis J; 2007 Dec 15; 26(12):1165-6. PubMed ID: 18043463
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Invasive zygomycosis in transplant recipients.
    Uçkay I, Chalandon Y, Sartoretti P, Rohner P, Berney T, Hadaya K, van Delden C.
    Clin Transplant; 2007 Dec 15; 21(4):577-82. PubMed ID: 17645724
    [Abstract] [Full Text] [Related]

  • 14. Primary treatment of zygomycosis with liposomal amphotericin B: analysis of 28 cases.
    Shoham S, Magill SS, Merz WG, Gonzalez C, Seibel N, Buchanan WL, Knudsen TA, Sarkisova TA, Walsh TJ.
    Med Mycol; 2010 May 15; 48(3):511-7. PubMed ID: 19824881
    [Abstract] [Full Text] [Related]

  • 15. Lipid formulations of amphotericin B as first-line treatment of zygomycosis.
    Petrikkos GL.
    Clin Microbiol Infect; 2009 Oct 15; 15 Suppl 5():87-92. PubMed ID: 19754765
    [Abstract] [Full Text] [Related]

  • 16. Zygomycosis and diabetes mellitus.
    Lanternier F, Lortholary O.
    Clin Microbiol Infect; 2009 Oct 15; 15 Suppl 5():21-5. PubMed ID: 19754752
    [Abstract] [Full Text] [Related]

  • 17. Posaconazole as first line treatment for disseminated zygomycosis.
    Peel T, Daffy J, Thursky K, Stanley P, Buising K.
    Mycoses; 2008 Nov 15; 51(6):542-5. PubMed ID: 18422921
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Liposomal amphotericin B (AmBisome) efficacy in confirmed invasive aspergillosis and other filamentous fungal infections in immunocompromised hosts: a pooled analysis.
    Cordonnier C, Bresnik M, Ebrahimi R.
    Mycoses; 2007 May 15; 50(3):205-9. PubMed ID: 17472618
    [Abstract] [Full Text] [Related]

  • 20. Complete resolution of pulmonary Rhizopus oryzae infection with itraconazole treatment: more evidence of the utility of azoles for zygomycosis.
    Eisen DP, Robson J.
    Mycoses; 2004 Apr 15; 47(3-4):159-62. PubMed ID: 15078434
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.